foodborn
virus
particularli
human
noroviru
nv
hepat
viru
type
caus
concern
public
health
make
necessari
explor
novel
effect
techniqu
prevent
foodborn
viral
contamin
especi
minim
process
readytoeat
food
studi
aim
determin
antivir
activ
probiot
lactic
acid
bacterium
lab
felin
caliciviru
fcv
surrog
human
nv
bacteri
growth
medium
filtrat
bgmf
lactococcu
lacti
subsp
lacti
bacteri
cell
suspens
bc
evalu
separ
antivir
activ
fcv
grown
crandellrees
felin
kidney
crfk
cell
signific
antivir
effect
seen
crfk
cell
pretreat
either
bgmf
raw
ph
bgmf
bc
howev
pretreat
fcv
bgmf
bc
result
reduct
viru
titer
log
tissu
cultur
infecti
dose
tcid
log
tcid
respect
highest
reduct
fcv
infect
obtain
crfk
cell
cotreat
fcv
ph
bgmf
fcv
bc
log
tcid
log
tcid
respect
preliminari
result
encourag
indic
need
continu
studi
role
probiot
lab
inactiv
virus
variou
type
food
foodborn
ill
associ
contamin
food
continu
plagu
public
health
well
world
economi
econom
cost
foodborn
ill
approxim
billion
us
alon
scharff
enter
virus
particularli
human
noroviru
nv
hepat
viru
type
lead
caus
viral
foodborn
ill
anonym
koopman
duizer
human
nv
one
top
five
highestrank
pathogen
respect
total
cost
foodborn
ill
us
belong
famili
calicivirida
wellknown
caus
wintervomit
diseas
stomachflu
ecdc
scharff
us
center
diseas
control
prevent
report
nv
caus
million
case
acut
gastroenter
annual
us
lead
million
outpati
visit
emerg
room
visit
hospit
death
mostli
among
young
children
half
foodborn
diseas
outbreak
due
known
caus
report
cdc
attribut
nv
european
union
calicivirus
primarili
nv
respons
foodborn
viral
outbreak
european
food
safeti
author
minim
effect
food
process
method
inactiv
foodborn
virus
review
baert
et
al
faowho
hirneisen
et
al
addit
recent
experi
nv
varieti
food
reveal
freez
cool
mild
heat
treatment
minim
food
process
effect
significantli
reduc
viru
titer
mormann
et
al
thu
develop
novel
effici
safe
strategi
control
viral
contamin
food
great
interest
food
scientist
food
produc
regard
biopreserv
control
one
organ
anoth
receiv
much
attent
last
decad
et
al
among
natur
biolog
antagonist
lactic
acid
bacteria
lab
part
intestin
microflora
wide
use
product
ferment
food
bacteria
long
histori
use
food
known
benefici
health
effect
human
mani
compound
produc
lab
ferment
antimicrobi
activ
compound
includ
hydrogen
peroxid
organ
acid
diacetyl
hydroxyl
fatti
acid
proteinac
compound
bacteriocin
et
al
antagonist
effect
lab
pathogen
bacteria
eg
listeria
monocytogen
staphylococcu
aureu
staphylococcu
epidermidi
streptococcu
sanguin
proteu
mirabili
yersinia
spp
report
al
askari
et
al
cizeikien
et
al
et
al
koo
et
al
schwenning
et
al
recent
increas
interest
use
lab
probiot
bacteria
viral
inhibitor
coronaviru
maragkoudaki
et
al
herp
simplex
viru
khani
et
al
human
immunodefici
viru
et
al
influenza
viru
kobayashi
et
al
lee
et
al
youn
et
al
rotaviru
rv
maragkoudaki
et
al
vesicular
stomat
viru
vsv
et
al
lactococcu
lacti
formerli
streptococcu
lacti
one
import
lab
gramposit
bacterium
use
extens
product
butter
milk
chees
madigan
et
al
use
includ
product
pickl
veget
beer
wine
bread
ferment
foodstuff
soymilk
kefir
organ
homofer
metabol
produc
l
lactic
acid
et
al
also
produc
lactic
acid
cultur
low
ph
kerberg
et
al
capabl
produc
lactic
acid
one
reason
l
lacti
one
import
microorgan
dairi
food
industri
achiev
gra
gener
regard
safe
statu
fda
present
studi
undertaken
determin
antivir
activ
l
lacti
subsp
lacti
felin
caliciviru
fcv
surrog
nv
lactococcu
lacti
subsp
lacti
kindli
provid
dr
dan
osullivan
professor
food
microbiolog
depart
food
scienc
nutrit
univers
minnesota
strain
maintain
de
man
ragosa
sharp
mr
broth
oxoid
basingstok
england
supplement
vv
glycerol
cryoprotect
agent
bacterium
grown
ml
mr
broth
h
anaerob
condit
cultur
centrifug
min
supernat
collect
divid
two
portion
one
portion
measur
ph
filtersteril
use
lm
pvdf
membran
filter
millex
gv
millipor
bedford
label
raw
bgmf
second
portion
adjust
ph
use
sodium
hydroxid
solut
filtersteril
label
adjust
bgmf
bc
prepar
wash
pellet
bacteria
obtain
twice
steril
pepton
phosphat
water
broth
ppwb
fluka
switzerland
remov
excess
mr
follow
centrifug
min
wash
pellet
resuspend
ml
ppwb
viabl
bacteri
cell
count
determin
spectrophotometr
measur
optic
densiti
od
nm
cellfre
ppwb
blank
standard
curv
creat
plot
od
serial
dilut
standard
bc
versu
mathemat
calcul
coloni
form
unit
cfu
ml
dilut
cfuml
standard
bc
measur
initi
use
plate
count
techniqu
mr
agar
plate
crandellrees
felin
kidney
crfk
cell
line
obtain
veterinari
diagnost
laboratori
univers
minnesota
usa
cell
grown
corn
cellgro
minimum
essenti
medium
mem
earl
salt
lglutamin
mediatech
inc
usa
supplement
fetal
bovin
serum
fb
standard
food
environ
virol
antibiot
co
tissu
cultur
flask
confluent
monolay
cell
form
cell
cultur
regularli
passag
perform
biolog
assay
cell
seed
well
plate
cellswel
incub
h
co
reach
monolay
fcv
strain
use
experi
viru
propag
crfk
monolay
flask
contain
crfk
cell
monolay
infect
fcv
cytopath
effect
cpe
observ
invert
microscop
h
infect
incub
supernat
contain
viru
collect
freez
thaw
three
time
follow
centrifug
min
viru
store
use
viru
titrat
tissu
cultur
infecti
dose
tcid
method
use
serial
dilut
sampl
prepar
mem
contain
fb
inocul
confluent
crfk
monolay
prepar
microtit
plate
use
three
well
per
dilut
cell
examin
develop
cpe
daili
day
endpoint
taken
highest
dilut
viru
produc
cpe
inocul
cell
viral
titer
calcul
karber
formula
express
tcid
ml
minimum
nontox
dilut
mntd
type
bgmf
determin
base
cellular
morpholog
alter
method
describ
orhan
et
al
briefli
sever
dilut
bgmf
prepar
mem
inocul
monolay
crfk
cell
contain
micropl
llwell
follow
incub
h
co
dilut
toxic
viabl
cell
label
nontox
also
compar
nontreat
cell
neg
control
confirm
lowest
nontox
dilut
chosen
mntd
antifcv
activ
l
lacti
metabolit
assay
three
differ
method
fcv
titer
treat
nontreat
viru
cell
control
calcul
pretreat
cell
bgmf
discard
growth
medium
crfk
cell
monolay
cover
nontox
dilut
mntd
two
differ
type
bgmf
dilut
undilut
raw
ph
bgmf
respect
incub
co
incub
variou
incub
time
min
min
h
monolay
wash
mem
immedi
wash
monolay
infect
fcv
serial
dilut
ii
pretreat
cell
bc
crfk
monolay
incub
bc
cfuml
min
co
incub
incub
nonbound
bacteria
remov
wash
two
time
mem
monolay
infect
fcv
dilut
iii
pretreat
viru
bgmf
aliquot
fcv
suspens
mix
separ
equal
volum
raw
bgmf
ph
bgmf
undilut
ml
steril
eppendorf
tube
incub
co
incub
differ
time
min
min
h
serial
dilut
prepar
mixtur
follow
infect
crfk
monolay
iv
pretreat
viru
bc
viru
adsorpt
bacteri
cell
aliquot
fcv
suspens
separ
mix
equal
volum
bc
contain
differ
bacteri
cell
count
cfu
ml
steril
eppendorf
tube
incub
co
incub
differ
time
min
min
h
mixtur
centrifug
min
serial
dilut
supernat
prepar
mem
dilut
use
infect
crfk
monolay
titrat
v
cotreat
cell
viru
bgmf
serial
dilut
fcv
prepar
differ
solut
raw
bgmf
ph
bgmf
diluent
follow
infect
crfk
monolay
three
differ
dilut
raw
bgmf
ph
bgmf
undilut
vv
mem
medium
use
respect
vi
cotreat
crfk
cell
bc
viru
crfk
monolay
inocul
bc
cfuml
immedi
monolay
infect
serial
dilut
fcv
prepar
mem
fifth
day
incub
well
wash
two
time
mem
remov
bacteri
cell
overlay
layer
prevent
observ
cpe
microscop
cell
control
bacterialtr
cell
control
well
done
discrimin
cpe
versu
intact
cell
normal
cpe
versu
bacterialcontamin
cell
respect
titrat
carri
triplic
experi
triplic
result
mean
standard
deviat
analysi
varianc
anova
gener
f
test
statist
analysi
carri
use
statistica
softwar
v
statsoft
inc
usa
raw
bgmf
exhibit
toxic
crfk
cell
dilut
higher
dilut
exhibit
toxic
hand
ph
bgmf
show
toxic
dilut
undilut
form
antivir
activ
l
lacti
pretreat
cell
bgmf
crfk
cell
pretreat
raw
ph
bgmf
mntd
dilut
respect
min
min
h
shown
fig
signific
decreas
p
c
fcv
titer
pretreat
crfk
cell
either
raw
ph
bgmf
time
pretreat
also
signific
effect
p
c
ii
pretreat
cell
bc
crfk
cell
pretreat
variou
bc
volum
examin
effect
number
bacteri
cell
capabl
crfk
cell
support
fcv
replic
cell
pretreat
min
bc
volum
except
littl
decreas
fcv
titer
log
tcid
ml
crfk
treat
bc
min
neither
bacteri
cell
count
treatment
time
signific
effect
fcv
titer
p
data
shown
iii
pretreat
fcv
bgmf
pretreat
fcv
raw
bgmf
min
min
h
result
signific
reduct
p
fcv
titer
approxim
log
tcid
ml
respect
wherea
pretreat
ph
bgmf
led
nonsignific
decreas
p
c
pretreat
time
fig
iv
pretreat
fcv
bc
viru
adsorpt
bacteri
cell
pretreat
fcv
bc
contain
cfu
l
lacti
result
nonsignific
decreas
p
c
fcv
titer
either
min
fig
howev
viru
titer
significantli
reduc
p
viru
treat
h
bc
contain
cfu
approxim
log
tcid
ml
reduct
respect
v
cotreat
cell
viru
bgmf
cotreat
crfk
simultan
bgmf
fcv
viru
infect
led
signific
decreas
fcv
titer
p
fig
highest
decreas
viru
titer
log
tcid
ml
obtain
cotreat
ph
bgmf
mntd
dilut
lower
decreas
fcv
titer
higher
dilut
ph
bgmf
log
tcid
ml
dilut
similar
trend
seen
cotreat
raw
bgmf
highest
decreas
fcv
p
attain
mntd
dilut
raw
bgmf
follow
dilut
log
tcid
ml
reduct
respect
highest
dilut
show
nonsignific
decreas
viru
titer
tcid
ml
vi
cotreat
cell
bc
viru
cotreat
crfk
monolay
differ
volum
bc
cfuml
simultan
fcv
infect
result
signific
decreas
p
fcv
titer
versu
titer
control
monolay
without
bc
highest
decreas
fcv
titer
log
tcid
ml
attain
treatment
follow
approxim
log
tcid
ml
crfk
monolay
treat
bc
respect
fig
statist
signific
differ
p
c
decreas
valu
attribut
three
bc
volum
use
studi
antivir
activ
lab
probiot
l
lacti
ssp
lacti
chosen
model
common
lab
probiot
properti
heoa
et
al
fcv
chosen
surrog
nv
former
grow
vitro
although
sever
attempt
made
accomplish
task
guix
et
al
malik
et
al
straub
et
al
addit
fcv
use
surrog
evalu
efficaci
common
preserv
process
use
food
industri
baert
et
al
butot
et
al
fcv
belong
calicivirida
famili
human
nv
bidawid
et
al
dsouza
et
al
avoid
interfer
bgmf
toxic
viral
cpe
preliminari
cytotox
assay
done
determin
mntd
type
bgmf
cytotox
raw
bgmf
dilut
may
due
low
ph
ph
respect
sinc
dilut
ph
bgmf
show
toxic
pretreat
crfk
cell
bgmf
bc
nonsignific
decreas
fcv
titer
rang
less
one
log
tcid
ml
result
agreement
earlier
report
vsv
infect
diminish
cell
pretreat
bgmf
bc
certain
lab
strain
et
al
signific
timedepend
decreas
fcv
titer
obtain
pretreat
fcv
raw
bgmf
ph
bgmf
main
differ
two
type
bgmf
statu
lactic
acid
excret
growth
medium
l
lacti
lactic
acid
neutral
sodium
hydroxid
ph
bgmf
therefor
effect
elimin
transform
lactic
acid
sodium
salt
sodium
lactat
ph
explan
support
similar
studi
pretreat
fcv
llactic
acid
solut
ph
led
log
reduct
fcv
titer
straub
et
al
ph
undilut
raw
bgmf
studi
hypothes
viral
capsid
protein
denatur
due
effect
acid
ph
nonenvelop
virus
rodger
et
al
straub
et
al
thu
prevent
viral
attach
host
cell
pretreat
fcv
bc
result
decreas
viru
titer
h
min
similarli
et
al
report
reduct
infect
vsv
h
incub
differ
lab
strain
attribut
reduct
adsorpt
bind
viru
surfac
lab
strain
probabl
peptidoglycan
cell
wall
lab
trap
viru
et
al
cell
wall
l
lacti
also
known
peptidoglycan
structur
consist
peptidoglycan
monom
primari
structur
glcnacmurnaclalaadglullysdala
dasp
interpeptid
bridg
attach
aamino
group
ly
courtin
et
al
lactobacillu
strain
shown
trap
hiv
virion
bind
mannos
sugar
rich
dome
attach
glycoprotein
gp
carlson
et
al
chang
et
al
similar
mechan
may
also
work
bacteriumviru
interact
system
present
studi
cotreat
experi
fcv
titer
reduc
type
bgmf
complet
inhibit
fcv
infect
attain
undilut
ph
bgmf
use
fig
hypothes
extracellular
metabolit
l
lacti
excret
bgmf
might
prevent
attach
fcv
cell
affect
entranc
cell
observ
antivir
activ
ph
bgmf
indic
lactic
acid
may
key
factor
action
transform
sodium
lactat
ph
adjust
bgmf
report
previous
metabolit
l
lacti
bacteriocin
et
al
choi
et
al
et
al
hydrogen
peroxid
grufferti
condon
et
al
van
niel
et
al
may
respons
action
antivir
activ
bacteriocin
bacteriocinlik
substanc
produc
lab
probiot
certain
bacteria
report
ermolenko
et
al
saeed
et
al
todorov
et
al
torr
et
al
wachsman
et
al
hydrogen
peroxid
also
wellknown
antivir
substanc
robert
antonoplo
antivir
activ
probiot
bacteria
vsv
attribut
metabolit
et
al
coinfect
crfk
fcv
bc
show
log
tcid
ml
reduct
fcv
infect
fig
similar
work
infect
vsv
decreas
cell
coinfect
vsv
differ
lab
strain
lactobacilli
bifidobacteria
vsv
et
al
result
also
agreement
maragkoudaki
et
al
observ
signific
decreas
infect
transmiss
gastroenter
coronaviru
tgev
rv
host
cell
coinfect
virus
presenc
lactobacillu
sp
hypothes
lab
cell
induc
releas
reactiv
oxygen
speci
noand
h
may
respons
kill
studi
virus
tgev
rv
maragkoudaki
et
al
competit
bacteri
cell
fcv
attach
function
receptor
cell
may
also
help
elucid
result
also
possibl
lab
may
establish
cross
talk
sort
signal
alter
state
epitheli
cell
macrophag
lead
antivir
respons
suggest
et
al
final
four
possibl
mechan
antifcv
effect
l
lacti
subsp
lacti
propos
first
lower
ph
relat
excret
lactic
acid
lab
may
respons
denatur
capsid
protein
viru
prevent
attach
host
cell
second
peptidoglycan
structur
lab
may
trap
viral
particl
third
product
differ
metabolit
bacteriocin
hydrogen
peroxid
prevent
entranc
viru
host
cell
therebi
inhibit
replic
final
competit
bacteri
cell
viru
attach
host
cell
may
occur
addit
induct
effect
bacterium
food
environ
virol
host
cell
produc
reactiv
oxygen
substanc
might
kill
viru
conclus
studi
report
first
time
antivir
effect
l
lacti
subsp
lacti
dual
model
lab
probiot
fcv
human
nv
surrog
indic
lab
probioticsbas
ferment
food
may
hold
promis
prevent
foodborn
virus
bacteria
hold
promis
biopreserv
agent
control
contamin
food
virus
although
preliminari
result
present
particular
import
merit
investig
understand
deepli
mechan
lab
probiot
antivir
effect
studi
activ
food
model
